155 related articles for article (PubMed ID: 9692307)
21. A curious case of cholestasis: oral terbinafine associated with cholestatic jaundice and subsequent erythema nodosum.
Kumar K; Gill A; Shafei R; Wright JL
BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25480138
[TBL] [Abstract][Full Text] [Related]
22. [Terbinafine induced hepatitis with persistent cholestasis].
Gendre G; Buclin T; Morard I; Fontannaz J; Berney JL
Rev Med Suisse; 2008 Mar; 4(149):736-9. PubMed ID: 18472735
[No Abstract] [Full Text] [Related]
23. Terbinafine: tolerability in general medical practice.
O'Sullivan DP
Br J Dermatol; 1999 Nov; 141 Suppl 56():21-5. PubMed ID: 10730910
[TBL] [Abstract][Full Text] [Related]
24. Terbinafine therapy may be associated with the development of psoriasis de novo or its exacerbation: four case reports and a review of drug-induced psoriasis.
Gupta AK; Sibbald RG; Knowles SR; Lynde CW; Shear NH
J Am Acad Dermatol; 1997 May; 36(5 Pt 2):858-62. PubMed ID: 9146568
[TBL] [Abstract][Full Text] [Related]
25. A Case of Progressive Cholestatic Drug-Induced Liver Injury Due to Terbinafine.
Ley D; Musto J; Said A
WMJ; 2023 May; 122(2):138-142. PubMed ID: 37141482
[TBL] [Abstract][Full Text] [Related]
26. [Acute hepatitis related to the ingestion of terbinafine].
Vantaux P; Grasset D; Nougue J; Lagier E; Seigneuric C
Gastroenterol Clin Biol; 1996; 20(4):402-3. PubMed ID: 8758509
[No Abstract] [Full Text] [Related]
27. Ursodeoxycholic acid for terbinafine-induced toxic hepatitis.
Agca E; Akcay A; Simsek H
Ann Pharmacother; 2004 Jun; 38(6):1088-9. PubMed ID: 15122001
[No Abstract] [Full Text] [Related]
28. Acute generalized exanthematous pustulosis induced by terbinafine.
Taberner R; Puig L; Gilaberte M; Alomar A
Eur J Dermatol; 2003; 13(3):313-4. PubMed ID: 12805000
[TBL] [Abstract][Full Text] [Related]
29. Oral terbinafine and erythema multiforme.
Todd P; Halpern S; Munro DD
Clin Exp Dermatol; 1995 May; 20(3):247-8. PubMed ID: 7671425
[TBL] [Abstract][Full Text] [Related]
30. Terbinafine-induced liver injury.
Kaushal M; Tolani P; Kumar N; Sharma S
Natl Med J India; 2017; 30(6):321-323. PubMed ID: 30117442
[TBL] [Abstract][Full Text] [Related]
31. Safety of oral terbinafine: results of a postmarketing surveillance study in 25,884 patients.
Hall M; Monka C; Krupp P; O'Sullivan D
Arch Dermatol; 1997 Oct; 133(10):1213-9. PubMed ID: 9382559
[TBL] [Abstract][Full Text] [Related]
32. Short-duration therapy with terbinafine for dermatophyte onychomycosis: a multicentre trial.
Goodfield MJ
Br J Dermatol; 1992 Feb; 126 Suppl 39():33-5. PubMed ID: 1531926
[TBL] [Abstract][Full Text] [Related]
33. Oral antifungal-exacerbated inflammatory flare-up reactions of dermatomycosis : case reports and review of the literature.
Nikkels AF; Nikkels-Tassoudji N; Piérard GE
Am J Clin Dermatol; 2006; 7(5):327-31. PubMed ID: 17007544
[TBL] [Abstract][Full Text] [Related]
34. Objective assessment of terbinafine-induced taste loss.
Doty RL; Haxel BR
Laryngoscope; 2005 Nov; 115(11):2035-7. PubMed ID: 16319619
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
Gupta AK; Gregurek-Novak T
Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230
[TBL] [Abstract][Full Text] [Related]
36. Terbinafine-induced lichenoid drug eruption.
Zheng Y; Zhang J; Chen H; Lai W; Maibach HI
Cutan Ocul Toxicol; 2017 Mar; 36(1):101-103. PubMed ID: 26938740
[TBL] [Abstract][Full Text] [Related]
37. Itraconazole, terbinafine possibly linked to liver failure.
Am J Health Syst Pharm; 2001 Jun; 58(12):1076. PubMed ID: 11449844
[No Abstract] [Full Text] [Related]
38. A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region.
Baran R; Feuilhade M; Combernale P; Datry A; Goettmann S; Pietrini P; Viguie C; Badillet G; Larnier C; Czernielewski J
Br J Dermatol; 2000 Jun; 142(6):1177-83. PubMed ID: 10848743
[TBL] [Abstract][Full Text] [Related]
39. Terbinafine induced pityriasis rosea-like eruption.
George A; Bhatia A; Kanish B; Williams A
Indian J Pharmacol; 2015; 47(6):680-1. PubMed ID: 26729964
[TBL] [Abstract][Full Text] [Related]
40. Oral terbinafine-induced bullous pemphigoid.
Aksakal BA; Ozsoy E; Arnavut O; Ali Gürer M
Ann Pharmacother; 2003 Nov; 37(11):1625-7. PubMed ID: 14565807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
